Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

To help aging populations, classify organismal senescence.

Calimport SRG, Bentley BL, Stewart CE, Pawelec G, Scuteri A, Vinciguerra M, Slack C, Chen D, Harries LW, Marchant G, Fleming GA, Conboy M, Antebi A, Small GW, Gil J, Lakatta EG, Richardson A, Rosen C, Nikolich K, Wyss-Coray T, Steinman L, Montine T, de Magalhães JP, Campisi J, Church G.

Science. 2019 Nov 1;366(6465):576-578. doi: 10.1126/science.aay7319. No abstract available.

2.

Filling the Governance Gap: International Principles for Responsible Development of Neurotechnologies.

Marchant G, Tournas L.

AJOB Neurosci. 2019 Oct-Dec;10(4):176-178. doi: 10.1080/21507740.2019.1665135. No abstract available.

PMID:
31642746
3.

[Reducing the amount of time spent sitting in a professional setting: the “Sedentariness at Work” (SAW) survey]

Marchant G, Nicaise V, Chastin S, Boiché J.

Sante Publique. 2019 May June;Vol. 31(3):377-385. doi: 10.3917/spub.193.0377. French.

PMID:
31640325
4.

What Are Best Practices for Ethical Use of Nanosensors for Worker Surveillance?

Marchant GE.

AMA J Ethics. 2019 Apr 1;21(4):E356-362. doi: 10.1001/amajethics.2019.356.

5.

Intention and automaticity toward physical and sedentary screen-based leisure activities in adolescents: A profile perspective.

Marchant G, Chevance G, Boiché J.

J Sport Health Sci. 2018 Oct;7(4):481-488. doi: 10.1016/j.jshs.2016.08.006. Epub 2016 Aug 23.

6.

Transgenerational epigenetics and environmental justice.

Rothstein MA, Harrell HL, Marchant GE.

Environ Epigenet. 2017 Aug 3;3(3):dvx011. doi: 10.1093/eep/dvx011. eCollection 2017 Jul. Review.

7.

Beyond Cost-Benefit Analysis in the Governance of Synthetic Biology.

Wallach W, Saner M, Marchant G.

Hastings Cent Rep. 2018 Jan;48 Suppl 1:S70-S77. doi: 10.1002/hast.822.

PMID:
29453841
8.

Physicians' duty to recontact and update genetic advice.

Stevens YA, Senner GD, Marchant GE.

Per Med. 2017;14(4):367-374. doi: 10.2217/pme-2017-0012. Epub 2017 Jun 8.

9.

Human Embryo Editing: Opportunities and Importance of Transnational Cooperation.

Pei D, Beier DW, Levy-Lahad E, Marchant G, Rossant J, Izpisua Belmonte JC, Lovell-Badge R, Jaenisch R, Charo A, Baltimore D.

Cell Stem Cell. 2017 Oct 5;21(4):423-426. doi: 10.1016/j.stem.2017.09.010.

10.

Advancing alternatives analysis: The role of predictive toxicology in selecting safer chemical products and processes.

Malloy T, Zaunbrecher V, Beryt E, Judson R, Tice R, Allard P, Blake A, Cote I, Godwin H, Heine L, Kerzic P, Kostal J, Marchant G, McPartland J, Moran K, Nel A, Ogunseitan O, Rossi M, Thayer K, Tickner J, Whittaker M, Zarker K.

Integr Environ Assess Manag. 2017 Sep;13(5):915-925. doi: 10.1002/ieam.1923. Epub 2017 May 21. Review.

11.

Big data in the era of precision medicine: big promise or big liability?

Issa AM, Marchant GE, Campos-Outcalt D.

Per Med. 2016 Jul;13(4):283-285. doi: 10.2217/pme-2016-0044. Epub 2016 May 25. No abstract available.

PMID:
29749809
12.

Contrasting Medical and Legal Standards of Evidence: A Precision Medicine Case Study.

Marchant GE, Scheckel K, Campos-Outcalt D.

J Law Med Ethics. 2016 Mar;44(1):194-204. doi: 10.1177/1073110516644210.

13.

A new window of opportunity to reject process-based biotechnology regulation.

Marchant GE, Stevens YA.

GM Crops Food. 2015;6(4):233-42. doi: 10.1080/21645698.2015.1134406.

14.
15.

Predictive testing for Alzheimer's disease: suicidal ideation in healthy participants.

Caselli RJ, Marchant GE, Hunt KS, Henslin BR, Kosiorek HE, Langbaum J, Robert JS, Dueck AC.

Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):252-4. doi: 10.1097/WAD.0000000000000097. No abstract available.

16.

The value of multigene predictors of clinical outcome in breast cancer: an analysis of the evidence.

Issa AM, Chaudhari VS, Marchant GE.

Expert Rev Mol Diagn. 2015 Feb;15(2):277-86. doi: 10.1586/14737159.2015.983476. Epub 2014 Dec 5. Review.

17.

Public perceptions of presymptomatic testing for Alzheimer disease.

Caselli RJ, Langbaum J, Marchant GE, Lindor RA, Hunt KS, Henslin BR, Dueck AC, Robert JS.

Mayo Clin Proc. 2014 Oct;89(10):1389-96. doi: 10.1016/j.mayocp.2014.05.016. Epub 2014 Aug 26.

18.

Is there a time or circumstance in the 3rd stage of labor when it is appropriate to massage the fundus?

McLean MT, Marchant G, Rannisi C, Hagen L, Hart G, Crosmun J, Keeslar I, DiNatale S.

Midwifery Today Int Midwife. 2014 Summer;(110):66-7. No abstract available.

PMID:
25112078
19.

Involuntary exposures to love-enhancing or anti-love agents.

Marchant GE, Stevens YA.

Am J Bioeth. 2013;13(11):26-7. doi: 10.1080/15265161.2013.839758. No abstract available.

PMID:
24161175
20.

Personalized medicine and genetic malpractice.

Marchant GE, Lindor RA.

Genet Med. 2013 Dec;15(12):921-2. doi: 10.1038/gim.2013.142. Epub 2013 Sep 26. No abstract available.

21.

The labeling debate in the United States.

Marchant GE, Cardineau GA.

GM Crops Food. 2013 Jul-Dec;4(3):126-34. doi: 10.4161/gmcr.26163. Epub 2013 Aug 26.

PMID:
23982076
22.

Regulatory and reimbursement innovation.

Lindor RA, Allocco SJ, Cheatham L, Cortese DA, Hall RF, Mangold WJ Jr, Pizziconi V, Poste G, Quinn B, Roth M, Saks MJ, Wassman ER, Woosley RL, Marchant GE.

Sci Transl Med. 2013 Mar 13;5(176):176cm3. doi: 10.1126/scitranslmed.3005437.

PMID:
23486776
23.

Prudent precaution in clinical trials of nanomedicines.

Marchant GE, Lindor RA.

J Law Med Ethics. 2012 Winter;40(4):831-40. doi: 10.1111/j.1748-720X.2012.00711.x.

PMID:
23289685
24.

Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field.

Fatehi L, Wolf SM, McCullough J, Hall R, Lawrenz F, Kahn JP, Jones C, Campbell SA, Dresser RS, Erdman AG, Haynes CL, Hoerr RA, Hogle LF, Keane MA, Khushf G, King NM, Kokkoli E, Marchant G, Maynard AD, Philbert M, Ramachandran G, Siegel RA, Wickline S.

J Law Med Ethics. 2012 Winter;40(4):716-50. doi: 10.1111/j.1748-720X.2012.00703.x.

25.

Physician liability: the next big thing for personalized medicine?

Marchant GE, Campos-Outcalt DE, Lindor RA.

Per Med. 2011 Jul;8(4):457-467. doi: 10.2217/pme.11.33.

PMID:
29783333
26.

The benefits and challenges of a voluntary occupational exposure database.

Marchant GE, Crane A.

J Occup Environ Med. 2011 Jun;53(6 Suppl):S52-6. doi: 10.1097/JOM.0b013e31821b175f.

PMID:
21654418
27.

What does the history of technology regulation teach us about nano oversight?

Marchant GE, Sylvester DJ, Abbott KW.

J Law Med Ethics. 2009 Winter;37(4):724-31. doi: 10.1111/j.1748-720X.2009.00443.x.

PMID:
20122112
28.

Editors' overview: forbidding science?

Marchant GE, Bird SJ.

Sci Eng Ethics. 2009 Sep;15(3):263-9. doi: 10.1007/s11948-009-9146-1. Epub 2009 Jun 27. No abstract available.

PMID:
19562518
29.

The ghost in our genes: legal and ethical implications of epigenetics.

Rothstein MA, Cai Y, Marchant GE.

Health Matrix Clevel. 2009 Winter;19(1):1-62.

30.

The problems with forbidding science.

Marchant GE, Pope LL.

Sci Eng Ethics. 2009 Sep;15(3):375-94. doi: 10.1007/s11948-009-9130-9. Epub 2009 Apr 7.

PMID:
19350416
31.

Ethical implications of epigenetics research.

Rothstein MA, Cai Y, Marchant GE.

Nat Rev Genet. 2009 Apr;10(4):224. doi: 10.1038/nrg2562. No abstract available.

32.

Applications and findings of an occupational exposure database for synthetic vitreous fibers.

Marchant G, Bullock C, Carter C, Connelly R, Crane A, Fayerweather W, Johnson K, Reynolds J.

J Occup Environ Hyg. 2009 Mar;6(3):143-50. doi: 10.1080/15459620802664382.

PMID:
19116861
33.

Hormesis and toxic torts.

Marchant GE.

Hum Exp Toxicol. 2008 Feb;27(2):97-107. doi: 10.1177/0960327107086567.

PMID:
18480129
34.

Transnational models for regulation of nanotechnology.

Marchant GE, Sylvester DJ.

J Law Med Ethics. 2006 Winter;34(4):714-25.

PMID:
17199813
35.

A proboscidean from the late Oligocene of Eritrea, a "missing link" between early Elephantiformes and Elephantimorpha, and biogeographic implications.

Shoshani J, Walter RC, Abraha M, Berhe S, Tassy P, Sanders WJ, Marchant GH, Libsekal Y, Ghirmai T, Zinner D.

Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17296-301. Epub 2006 Nov 3. Erratum in: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):1103.

36.

Legal pressures and incentives for personalized medicine.

Marchant GE, Milligan RJ, Wilhelmi B.

Per Med. 2006 Nov;3(4):391-397. doi: 10.2217/17410541.3.4.391.

PMID:
29788592
37.

Elephant brain. Part I: gross morphology, functions, comparative anatomy, and evolution.

Shoshani J, Kupsky WJ, Marchant GH.

Brain Res Bull. 2006 Jun 30;70(2):124-57. Epub 2006 Apr 18.

PMID:
16782503
38.

[Laparoscopic nephrectomies: initial experience of a community hospital].

Valero G, Rendic C, Marchant G, González EU.

Actas Urol Esp. 2006 Mar;30(3):301-4. Spanish.

PMID:
16749587
39.

Genetic samples and genetic philanthropy.

Berens ME, Marchant GE.

Virtual Mentor. 2004 Nov 1;6(11). pii: virtualmentor.2004.6.11.pfor2-0411. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411. No abstract available.

40.

From general policy to legal rule: aspirations and limitations of the precautionary principle.

Marchant GE.

Environ Health Perspect. 2003 Nov;111(14):1799-803. Review.

41.

Metacognitive ability from a theory-of-mind perspective: a cross-cultural study of students with and without hearing loss.

al-Hilawani YA, Easterbrooks SR, Marchant GJ.

Am Ann Deaf. 2002 Oct;147(4):38-47.

PMID:
12592804
42.

Use of genomics in toxicology and epidemiology: findings and recommendations of a workshop.

Henry CJ, Phillips R, Carpanini F, Corton JC, Craig K, Igarashi K, Leboeuf R, Marchant G, Osborn K, Pennie WD, Smith LL, Teta MJ, Vu V.

Environ Health Perspect. 2002 Oct;110(10):1047-50.

43.

Toxicogenomics and toxic torts.

Marchant GE.

Trends Biotechnol. 2002 Aug;20(8):329-32.

PMID:
12127279
44.
45.

Genetics and toxic torts.

Marchant GE.

Seton Hall Law Rev. 2001;31(4):949-82. No abstract available.

PMID:
11963951
46.

A synthetic vitreous fiber (SVF) occupational exposure database: implementing the SVF Health and Safety Partnership Program.

Marchant GE, Amen MA, Bullock CH, Carter CM, Johnson KA, Reynolds JW, Connelly FR, Crane AE.

Appl Occup Environ Hyg. 2002 Apr;17(4):276-85.

PMID:
11942671
47.

A regulatory precedent for hormesis.

Marchant GE.

Hum Exp Toxicol. 2001 Mar;20(3):143-4. No abstract available.

PMID:
11326778
50.

Design philosophy of air quality surveillance systems.

Marchant GR, Hales DB, Whatcott GL.

ISA Trans. 1975;14(2):137-44.

PMID:
1176275

Supplemental Content

Loading ...
Support Center